Document is current
Any future updates will be listed below
-
Authors
Bhattacharya, Atrayee
Fushimi, Atsushi
Wang, Keyi
Yamashita, Nami
Morimoto, Yoshihiro
Ishikawa, Satoshi
Daimon, Tatsuaki
Liu, Tao https://orcid.org/0000-0002-8818-8313
Liu, Song
Long, Mark D. https://orcid.org/0000-0003-1120-8176
Kufe, Donald https://orcid.org/0000-0001-5743-8888
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA97098, CA233084, CA262991, CA232979, OD024973)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 19 April 2023
Accepted: 27 September 2023
First Online: 11 October 2023
Competing interests
: D.K. has equity interests in Genus Oncology and Hillstream Biopharma and is a paid consultant to Reata and CanBas. The other authors declare no competing interests.
